Stay updated on DTX101 in Hemophilia B Adults: Safety & Dose Clinical Trial
Sign up to get notified when there's something new on the DTX101 in Hemophilia B Adults: Safety & Dose Clinical Trial page.

Latest updates to the DTX101 in Hemophilia B Adults: Safety & Dose Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe page’s footer/update indicator changed from “Revision: v3.5.2” to “Revision: v3.5.3,” reflecting a website release/version update rather than a change to the study record details.SummaryDifference0.1%

- Check15 days agoChange DetectedAdded revision v3.5.2 and removed revision v3.5.0.SummaryDifference0.1%

- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedAdds a related disease topic, Hereditary factor IX deficiency, and links to Genetic and Rare Diseases Information Center resources on the study page.SummaryDifference0.2%

- Check37 days agoChange DetectedHemophilia B is removed from the page content. The Genetic and Rare Diseases Information Center resource link in Resources is removed.SummaryDifference0.2%

- Check44 days agoChange DetectedThe page shows a revision label update from v3.4.3 to v3.5.0. It does not modify study details or related content.SummaryDifference0.1%

- Check51 days agoChange DetectedThe page now shows Revision: v3.4.3; the previous Revision: v3.4.2 has been removed.SummaryDifference0.1%

Stay in the know with updates to DTX101 in Hemophilia B Adults: Safety & Dose Clinical Trial
Enter your email address, and we'll notify you when there's something new on the DTX101 in Hemophilia B Adults: Safety & Dose Clinical Trial page.